Thyrocare Technologies Limited — Others, 23-01-2025: Options to purchase securities

Thyrocare has announced a board meeting at which the Nomination and Remuneration Committee approved the grant of 2,823 Stock Options to eligible employees under the Thyrocare Employees Stock Option Scheme. Each option has a price of ₹10 and will vest within one to three years. This move is likely aimed at enhancing employee motivation and retention, signalling a commitment to workforce engagement. Investors may view this positively as it aligns with long-term growth strategies while potentially enhancing shareholder value.